Navigation Links
Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial
Date:11/28/2007

Company Plans to Initiate Phase III Program in First Half of 2008

LEXINGTON, Mass., Nov. 28 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced positive results from its Phase II octreotide implant trial in patients with acromegaly, a disorder characterized by excessive blood levels of growth hormone (GH) and insulin- like growth factor 1 (IGF-1). The implant utilizes the Company's patented Hydron technology to deliver effective levels of octreotide for six months. Octreotide is a synthetic peptide that mimics the natural hormone somatostatin to block release of GH. In the recently completed six-month trial, the octreotide implant effectively suppressed levels of GH and IGF-1 at rates similar to those seen with current FDA approved injectable formulations of octreotide. In addition, the drug was well tolerated.

"I am extremely pleased to report the successful completion of our octreotide implant trial and we are looking forward to the initiation of our Phase III program in the first half of 2008," stated Glenn L. Cooper, M.D., chairman and chief executive officer of Indevus. "The market opportunity for a six-month octreotide implant for the treatment of acromegaly is substantial. The results of the trial demonstrate the potential of our octreotide implant, the only once every six month treatment, to improve the treatment options for people who suffer from this life-long debilitating condition. In addition, based on the successful results of this trial, we are exploring opportunities to expand our octreotide development program to address other indications where injectable formulations of octreotide are currently utilized, including carcinoid tumors."

The trial w
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
2. Indevus Announces Submission of New Drug Application
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 18, 2014 Radiology ... that is used to store, manipulate, and distribute ... a patient tracking and scheduling system, result reporting, ... RIS with HIS and other databases improves the ... and patient scheduling, patient list management, radiology department ...
(Date:12/19/2014)... CITY, Calif., Dec. 18, 2014 Capnia, ... the development of medical diagnostics based on its ... gas flow, today announced financial results for the ... 2014. "Following the completion of our ... positioned to maximize the recently initiated CoSense® commercial ...
(Date:12/19/2014)... INDIANAPOLIS and LYON, France ... (NYSE: LLY ) and Adocia (Euronext Paris: ... focused on developing an ultra-rapid insulin, known as BioChaperone ... type 2 diabetes. BioChaperone Lispro relies on Adocia,s proprietary ... Lilly and Adocia will develop BioChaperone Lispro ...
Breaking Medicine Technology:The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3
... According to a new report by HHS, Agency for Healthcare Research ... for two gene mutations in adults with a history of blood ... to improve other clinical outcomes. , , The report, a ... of JAMA , also failed to find any ...
... Pain Relief and Improved Sleep Patterns , , ... Medical Association, stress is a factor in more than ... cites stress as America,s No. 1 Health Problem. And ... problem." An Arizona entrepreneur, however, is launching a business ...
Cached Medicine Technology:Value of Genetic Testing for Preventing Blood Clots Unproven, According to New AHRQ Study 2Value of Genetic Testing for Preventing Blood Clots Unproven, According to New AHRQ Study 3Scottsdale Facility to Be First in U.S. to Showcase True REST Technology 2Scottsdale Facility to Be First in U.S. to Showcase True REST Technology 3
(Date:12/20/2014)... Angeldress.co.uk, the distinguished wedding dress manufacturer and ... fans. The company has recently updated its official blog ... holiday season, Angeldress Blog has recommended some ... Angeldress.co.uk prides itself in offering a huge selection of ... the company’s outfits are very carefully selected based on ...
(Date:12/20/2014)... December 20, 2014 Recently, AngelWeddingDress.com has ... Discount ”) for the coming Christmas. In the promotion, ... 80% off. , “We have something special for the ... the holiday season. Moreover, our new collections of 2015 ... are offered now at greatly discounted prices. Visit our ...
(Date:12/20/2014)... Parker & Sons, Inc. a focused and dedicated ... contractor services announces reaching a milestone by providing 40 ... Arizona. Parker and Sons is comprised of a reliable ... customer service the number one priority. The company was ... one service vehicle and has since grown to become ...
(Date:12/19/2014)... Sweetdressy.com , a leading wedding ... newest selection of cheap prom dresses for ladies worldwide. ... the world and clients can buy these dresses at ... dresses feature cool cuts and delicate craftsmanship, and most ... middle-end market. Discount shipping costs are available for all ...
(Date:12/19/2014)... Missouri (PRWEB) December 19, 2014 Silver ... new official world record -- for the first time ever, ... prestigious record book, Guinness World Records 2015, listing the park’s ... Wooden Roller Coaster. In additional awards announced this week, Silver ... See Christmas Lights in the US,” USA Today’s 10Best awards ...
Breaking Medicine News(10 mins):Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 3Health News:Cheap Prom Dresses Online Now at Sweetdressy.com 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2
... History is expected to repeat itself and the campaign that ... the Princess Alexandra Eye Pavilion// in Lauriston looks set to ... eye operations to St John's in Livingston, a situation that ... about 40 miles for treatment. ,In 1998, about ...
... people are unaware that they face the higher risk of cancer ... ,The survey conducted in over 4,000 adults found that 40% thought ... were aware that it lessened cancer risk., ,"This research provides ... it comes to looking after our bodies and the low awareness ...
... Since the Shipman affair doctors have wary of treating elderly ... ,In 2000, Dr Harold Shipman was declared guilty of 15 ... higher. He took his own life in prison in 2004. ... on behalf of BBC Radio 4 revealed that since Shipman’s ...
... United States Department of Agriculture (USDA) has made available a ... Infants and Children, called the WIC in short. The USDA's ... and juice that form a part of the food packages. ... be brought down from two and a half dozen eggs ...
... Department of Defense-funded researcher has tried to unplug the ... effects// on decision-making and the requisite period for getting ... has been especially beneficial for the military operations, where ... the norm rather than the exception. ,"We can't ...
... Haemorrhagic Fever (CCHF) has killed at least 20 people in ... it was identified// in 1944, say the authorities. According to ... bound to be reported. By 4 August, 242 cases of ... Sea and Central Anatolia region: Tokat, Sivas, Gumushane, Amasya, Yozagat ...
Cached Medicine News:Health News:Doctors Wary after Shipman Affair 2Health News:Proposal to revamp WIC food package 2Health News:Understanding the Effects of Sleep Deprivation on Decision-Making 2Health News:Understanding the Effects of Sleep Deprivation on Decision-Making 3Health News:Crimean-Congo Hemorrhagic Fever hits Turkey 2
... C-terminal cleavage product produced during processing of ... molecule. Although the C-peptide of insulin is ... or extra-renal metabolism and therefore has a ... In addition, C-peptide assays may be analytically ...
... C-peptide of insulin is the C-terminal cleavage ... prohormone to the mature insulin molecule. Although ... it does undergo significant liver or extra-renal ... circulating half-life than insulin [1]. In addition, ...
... 1-2% of circulating testosterone exists as unbound ... is bound to SHBG with high affinity ... to albumin. Both the albumin-bound and free ... effectively inhibits testosterone action. Measurement of the ...
... the first, easy-to-use, non-invasive diagnostic technology ... cardiac dysfunction including acute heart failure, ... cardiac conditions. Designed to seamlessly fit ... enable clinicians caring for cardiac patients ...
Medicine Products: